Switching to long-acting injectable risperidone is beneficial with regard to clinical outcomes, regardless of previous conventional medication in patients with schizophrenia

  • De Marinis T
  • Saleem P
  • Glue P
 et al. 
  • 24

    Readers

    Mendeley users who have this article in their library.
  • 36

    Citations

    Citations of this article.

Abstract

Using an atypical long-acting antipsychotic may improve patient outcome by offering the good efficacy and tolerability of an atypical antipsychotic with improved compliance through depot administration.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • T. De Marinis

  • P. T. Saleem

  • P. Glue

  • W. J. Arnoldussen

  • R. Teijeiro

  • A. Lex

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free